Finding the correct dosage and combination of cannabinoid products for medical treatment is almost universally a long and expensive process of trial and error. And for the most part, patients are undertaking this journey alone and often with little guidance.
This week on The Cannabis Enigma Podcast we get together with Otha Smith III, CEO, and Founder at Tetragram, a smart, digital platform that helps users get the most out of medical cannabis. We each have a unique endocannabinoid system, which makes finding the right dosage and combination of products a challenging process. There is also a lack of access to healthcare professionals, and experts in the field, to guide patients through this complicated process. There is still a long way to go in building a model that serves all patients, but in the meantime, Tetragram is providing an essential service for bridging that gap. The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. It includes a space for journaling, an imperative aspect of improving your experience, as well as tools for determining the chemical profile of the cannabis you’re using and how that correlates with your experience with medical cannabis.
In our conversation with Otha, we talk about how Tetragram has been able to help its patients, how federal and state laws affect access to medical cannabis and what we can expect of government legislation in the coming years. We delve into how data can further our understanding of different types of cannabis and why standardization is desperately needed in the industry.
The Cannabis Enigma podcast is a co-production of The Cannigma and Americans for Safe Access. Elana Goldberg is the executive producer and co-host. Dr. Codi Peterson is co-producer and co-host. This episode was edited by our friends atWe Edit Podcasts. Music by Desca.
Links mentioned in this episode: